New Leadership at the American Brain Tumor Association
In an exciting development, the American Brain Tumor Association (ABTA) has appointed Kelly Sitkin as its new President and Chief Executive Officer. Sitkin's leadership is anticipated to usher in a fresh era for the organization, which has been a beacon of support for brain tumor patients and their families.
Kelly Sitkin Takes the Helm
Kelly Sitkin follows in the footsteps of Ralph DeVitto, who has led the ABTA for seven years. Sitkin previously served as the Chief Development Officer (CDO), where she played a significant role in increasing the organization’s total revenue by 45%, demonstrating her effectiveness in fostering growth and building strong community ties.
Achievements as Chief Development Officer
While at the helm of ABTA's development efforts, Sitkin successfully raised revenue from $6.3 million to an impressive $9.1 million between 2017 and 2023. Her strategic approach encompassed a comprehensive development plan which integrated a volunteer network to better serve patients and caregivers, ensuring that quality resources were available to those in need.
A Visionary Leader
Ralph DeVitto commended Sitkin's leadership style, highlighting her collaborative spirit and ability to inspire those around her. "Kelly is an amazing leader who knows the impact of collaboration," he remarked, indicating the trust and gratitude he holds towards her capabilities as she transitions into this key role.
Kelly Sitkin’s Background
With over two decades of experience in development, Sitkin is equipped to guide the ABTA while continuing the important work of advocating for brain tumor research. Her previous role at the University of Wisconsin Carbone Cancer Center, where she directed development and external relations, further solidifies her as a powerhouse in fundraising and community engagement.
Focusing on Critical Needs
Kelly Sitkin is passionate about the mission of the ABTA, believing that her experience and compassionate approach will enable her to elevate the organization’s visibility and impact. As she takes the reins, she aims to enhance resources for patients and their families while propelling research initiatives forward.
Major Campaign Initiatives
Under her leadership, the ABTA is set to advance its ambitious "Meet Hope Head On" campaign, with a goal of raising $50 million. This initiative aims to significantly increase research funding and expand the ABTA's outreach to better serve those affected by brain tumors. Currently, the ABTA has successfully raised $14 millions of the targeted goal.
About the American Brain Tumor Association
Founded in 1973, the American Brain Tumor Association is dedicated to providing comprehensive support and resources for brain tumor patients and caregivers of all ages. The organization plays a pivotal role in funding groundbreaking research and championing awareness to find effective treatments and cures for brain tumors. For more information, one can visit the ABTA website or contact their dedicated team.
Frequently Asked Questions
Who is Kelly Sitkin?
Kelly Sitkin is the newly appointed President and CEO of the American Brain Tumor Association, previously serving as its Chief Development Officer.
What did Kelly Sitkin accomplish as CDO?
As CDO, Sitkin increased ABTA's revenue by 45% and implemented an integrated development strategy benefiting patients and caregivers.
What is the "Meet Hope Head On" campaign?
This is an ambitious $50 million campaign aimed at boosting research funding and expanding the reach of ABTA to serve more patients.
What is the mission of the American Brain Tumor Association?
The ABTA is dedicated to supporting brain tumor patients and their families while funding research for better treatments and cures.
How can I get involved with the ABTA?
Individuals can support the ABTA through donations, volunteering, or participating in events that foster awareness and fundraising for brain tumor research.
